📰 Andreaf Wainer News
Page 41 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
January 9, 2024
Whittier Trust Co. grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 373,375 shares of the healthcare product maker’s stock after purchasing an additional 5,058 shares during the period. Whittier Trust Co.’s […]
January 9, 2024
Gradient Investments LLC raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 246,000 shares of the healthcare product maker’s stock after buying an additional 4,955 shares during […]
January 8, 2024
MTM Investment Management LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the third quarter, Holdings Channel reports. The institutional investor owned 6,227 shares of the healthcare product maker’s stock after selling 149 shares during the quarter. MTM Investment Management LLC’s holdings in Abbott Laboratories were worth $603,000 […]
January 8, 2024
MTM Investment Management LLC cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,227 shares of the healthcare product maker’s stock after selling 149 shares during the quarter. MTM Investment Management LLC’s holdings […]
January 8, 2024
Asset Advisors Investment Management LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,810 shares of the healthcare product maker’s stock after selling 1,097 shares during the quarter. Abbott […]
January 8, 2024
Osborne Partners Capital Management LLC lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 112,001 shares of the healthcare product maker’s stock after purchasing an […]
January 8, 2024
Osborne Partners Capital Management LLC increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 112,001 shares of the healthcare product maker’s stock after acquiring an additional 989 shares during the quarter. Osborne Partners Capital Management LLC’s holdings in Abbott Laboratories were worth $10,847,000 […]
January 8, 2024
Asset Advisors Investment Management LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 113,810 shares of the healthcare product maker’s stock after selling 1,097 shares during the […]
January 8, 2024
River Street Advisors LLC grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,635 shares of the healthcare product maker’s stock after acquiring an additional 707 shares during the quarter. River Street Advisors LLC’s […]
January 8, 2024
Absher Wealth Management LLC increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,867 shares of the healthcare product maker’s stock after buying an additional 8,423 shares during […]